• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

    20.07 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 66
    Open 20.07
    Bid (Size) 19.20 (21)
    Ask (Size) 20.09 (3)
    Prev. Close 20.07
    Today's Range 20.07 - 20.07
    52wk Range 7.080 - 20.65
    Shares Outstanding 407,265,944
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
    From Amarin Corporation plc
    Via GlobeNewswire

    Performance

    YTD
    +91.7%
    +91.7%
    1 Month
    +34.4%
    +34.4%
    3 Month
    +27.1%
    +27.1%
    6 Month
    +120.3%
    +120.3%
    1 Year
    +73.0%
    +73.0%

    More News

    Read More
    Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
    From Amarin Corporation plc
    Via GlobeNewswire
    Earnings Scheduled For July 30, 2025
    Via Benzinga
    Earnings Scheduled For May 7, 2025
    Via Benzinga
    Exploring Amarin Corp's Earnings Expectations
    Via Benzinga
    New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
    From Amarin Corporation plc
    Via GlobeNewswire
    New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin Reports Second Quarter 2025 Financial Results
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin Shares Surge After $175M European Licensing Deal For Heart Drug VAZKEPA
    Via Benzinga
    Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Which stocks are gapping on Tuesday?
    Via Chartmill
    Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin Reports First Quarter 2025 Financial Results
    From Amarin Corporation plc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
    From Amarin Corporation plc
    Via GlobeNewswire
    Top 2 Health Care Stocks That May Crash This Month
    Via Benzinga
    Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
    From Amarin Corporation plc
    Via GlobeNewswire

    Frequently Asked Questions

    Is Amarin Corporation plc - American Depositary Shares publicly traded?
    Yes, Amarin Corporation plc - American Depositary Shares is publicly traded.
    What exchange does Amarin Corporation plc - American Depositary Shares trade on?
    Amarin Corporation plc - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Amarin Corporation plc - American Depositary Shares?
    The ticker symbol for Amarin Corporation plc - American Depositary Shares is AMRN on the Nasdaq Stock Market
    What is the current price of Amarin Corporation plc - American Depositary Shares?
    The current price of Amarin Corporation plc - American Depositary Shares is 20.07
    When was Amarin Corporation plc - American Depositary Shares last traded?
    The last trade of Amarin Corporation plc - American Depositary Shares was at 10/16/25 04:00 PM ET
    What is the market capitalization of Amarin Corporation plc - American Depositary Shares?
    The market capitalization of Amarin Corporation plc - American Depositary Shares is 8.17B
    How many shares of Amarin Corporation plc - American Depositary Shares are outstanding?
    Amarin Corporation plc - American Depositary Shares has 8B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.